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The soluble receptor-resistant (srr) mutants, srr7 and srr11, isolated from a murine coronavirus, mouse hepatitis virus
(MHV) JHMV, have an amino acid mutation at positions 1114 (Leu to Phe) and 65 (Leu to His), respectively, in the spike (S)
protein. These mutants failed to efficiently infect BHK cells expressing CEACAM1b (BHK-R2), due to their low entry into this
cell line, although they infected cells expressing CEACAM1a (BHK-R1) in a manner similar to that of wild-type (wt) JHMV cl-2
(Matsuyama and Taguchi, Virology 273, 80–89, 2000). Following the repeated passage of these mutants through BHK-R2
cells, viruses were no longer isolated from srr11-infected cells, while two distinct mutants, srr7A and srr7B, were obtained
from srr7-infected cells. Srr7A and srr7B grew 2 log10 higher than srr7 and induced fusion in BHK-R2 cells, being similar to
wt virus. In addition to the amino acid change at position 1114 that stemmed from parental srr7, srr7A and srr7B had
mutations around position 280, corresponding to the third region of the S1N330 receptor-binding site (S1N330-III) common
to all MHV strains examined thus far. Srr7A and srr7B S proteins showed high fusogenicity in both BHK-R1 and BHK-R2 cells,
like the wt virus, while srr7Aa and srr7Ba S proteins, which had mutations in S1N330-III but not at amino acid 1114, exhibited
profoundly reduced fusion activity in these cell lines. These findings suggest that communication between S1N330-III and theINTRODUCTION
Mouse hepatitis virus (MHV), a member of the coro-
navirus family, causes a variety of diseases with different
organ tropisms and virulence, depending upon MHV
strains. The major target organs of MHV are the liver,
central nervous system, and intestines. The MHV virion
has a genome of single-stranded, positive-sense RNA of
about 31 kb in length which is packaged by a nucleo-
capsid (N) protein of about 50 kDa within the viral enve-
lope. The virion envelope contains an integral membrane
(M) protein of 20–23 kDa, envelope (E) protein of about 8
kDa, and spike (S) protein of 170–200 kDa. Some strains
of MHV have an optional protein, hemagglutinin-ester-
ase protein (60–65 kDa) on the envelope as well.
The S protein constitutes the projection or peplomer
on the virion surface. After being synthesized and mod-
ified by glycosylation, the S protein is cleaved into N
terminal S1 and C terminal S2 subunits by host cell-
derived proteases (Sturman et al., 1985). S1 comprises
the outermost, knob-like structure of the projection, and
the membrane-anchored S2, the stem-like structure be-
neath the knob (De Groot et al., 1987). In the middle of S1,
1 To whom correspondence and reprint requests should be ad-
dressed at Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Ko-there is a highly variable region spanning about 150
amino acids, called the hypervariable region (HVR). A
number of viruses and mutants have amino acid muta-
tions or deletions of variable lengths in this region rela-
tive to the largest S protein of MHV-JHMV (La Monica et
al., 1991; Parker et al., 1989; Taguchi et al., 1985; Wang et
al., 1992).
S protein has several important biological functions.
The N terminal region, consisting of 330 amino acids of
S1 (S1N330), is responsible for the binding to the recep-
tor, and the receptor-binding site is formed by a confor-
mational structure (Kubo et al., 1994). In S1N330, there
are three regions common to all MHV strains, S1N330-I,
II, and III, of which I and II are involved in receptor-
binding activity (Suzuki and Taguchi, 1996), while the
function of S1N330-III is not yet clarified. Amino acid Thr
at position 62, located in S1N330-I, and its neighboring
residues, are assumed to be particularly important for
receptor-binding activity (Suzuki and Taguchi, 1996). S
protein is also involved in the viral entry into cells via
fusion of the viral envelope and cell membrane (Collins
et al., 1982; Taguchi et al., 1992). Several different regions
in S2 are considered critical for this fusion activity (Gal-
lagher, 1996; Luo and Weiss, 1998; Taguchi and
Shimazaki, 2000). Cleavage events of S are not abso-
lutely necessary for fusion activity (Stauber et al., 1993;amino acid at position 1114 is important for efficient fusion
involved in viral entry into cells. © 2002 Elsevier Science (USA)
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Perlman, 1995; Flory et al., 1993). The key to determining
MHV virulence is believed to lie in the S protein (Dalziel
et al., 1986; Fleming et al., 1986; Matsuyama et al., 2001;
Phillip et al., 1999), and thus, it is critical to the early
events of virus infection, as well as for the host animals
to protect against MHV infection (Taguchi, 1999).
Several different proteins work as MHV receptors
(Chen et al., 1995; Dveksler et al., 1991; Nedellec et al.,
1994; Yokomori and Lai, 1992), among which CEACAM1
is the most functional receptor. Two allelic forms
are known for CEACAM1, CEACAM1a (MHVR1) and
CEACAM1b (MHVR2) (Beauchemin et al., 1999; Dveksler
et al., 1993; Yokomori and Lai, 1992). MHVR1 is ex-
pressed in most mouse strains with a high susceptibility
to MHV, while MHVR2 is derived from the SJL mouse
strain resistant to MHV (Dveksler et al., 1993; Ohtsuka
and Taguchi, 1997; Smith et al., 1984; Yokomori and Lai,
1992). MHVR1 is a 10- to 100-fold more functional recep-
tor for MHV than is MHVR2 (Ohtsuka et al., 1996; Rao et
al., 1997).
Mutant viruses resistant to neutralization by a soluble
receptor (srr) have been isolated from various viruses.
Generally, srr mutants fail to bind to a soluble receptor as
efficiently as they bind to the membrane-anchored re-
ceptor (Colston and Racaniello, 1994; Kaplan et al., 1990;
McKeating et al., 1991). However, some MHV srr mutants
isolated in our lab bound to both soluble and membrane-
anchored receptors as efficiently as the wt virus (Saeki et
al., 1997). Thus, the mechanism of soluble receptor-
resistance of those MHV mutants appeared to be differ-
ent from that of other viruses.
Recently, we found that our srr mutants failed to effi-
ciently infect cells expressing MHVR2 (BHK-R2), while
they infected cells expressing MHVR1 (BHK-R1) in a
fashion similar to the wt virus (Matsuyama and Taguchi,
2000). Inefficient srr infection in BHK-R2 cells was dem-
onstrated to be due to low fusionability, i.e., inefficient
entry into cell (Matsuyama and Taguchi, 2000). From
those srr mutants, we tried to isolate viruses that grow
well in BHK-R2, revertants in terms of growth capability in
BHK-R2 cells, to see whether any other region in the S
protein compensates for the inefficient fusogenicity
caused by the mutations in srr mutants. In the present
study, we show revertants successfully isolated from
srr7. Their characterization suggests the importance of
the communication between S1N330-III and a region in
S2 for the fusogenicity on BHK-R2 cells.
RESULTS
Isolation of mutant viruses from srr7
Srr7 and srr11 with a mutation at amino acid position
1114 (Leu to Phe) and 65 (Leu to His), respectively, failed
to grow as efficiently as the wt virus in BHK-R2 cells that
constitutively express MHVR2 receptor (Matsuyama and
Taguchi, 2000). To see whether some other amino acids
can compensate for the defects caused by these muta-
tions, we tried to isolate viruses that grow in BHK-R2
cells as efficiently as the wt virus by repeated passage of
these mutants through the cell line. These mutants,
5–10  105 PFU as examined using DBT cells, were
inoculated onto BHK-R2 cells and the cells were incu-
bated for 24 h after infection. Viruses grown in cells were
subjected to a subsequent cycle of infection onto
BHK-R2 cells. We repeated this passage 20 times. As for
srr11, syncytia ceased to form after three to four pas-
sages, and no infectious viruses were recovered from
cells in the fifth to sixth passage in two independent
experiments. In contrast, srr7 was successfully adapted
to grow in BHK-R2 cells. During the first two to four
passage levels, no remarkable syncytia were observed;
however, with repeated passages, syncytia became vis-
ible that were similar to those of wt virus. After 20
passages, we isolated viruses by plaque purification
using DBT cells. In two independent experiments, we
obtained two different viruses, srr7A and srr7B, that grew
in BHK-R2 cells more efficiently and produced larger
syncytia than did the parental srr7. These viruses were
detected after the 10th to 15th passage in BHK-R2 cells.
Biological characterization of srr7A and srr7B
Two viruses, srr7A and srr7B, isolated after the 20th
passage, were compared with the parental srr7, as well
as wt cl-2 in terms of the growth in BHK-R2 and BHK-R1
cells. Following infection at a multiplicity of infection
(m.o.i.) of 0.1 in BHK-R2 cells, progeny appeared in the
cells at 12 h postinoculation (p.i.) irrespective of the type
of viruses used. However, the titers of srr7A and srr7B
grown in this cell line were about 2 log10 higher than that
of parental srr7 throughout the course of infection, but
slightly lower (1 in log10) than the wt cl-2 titer. All of these
viruses reached a plateau at 18 to 24 h p.i. There was no
significant difference in the growth kinetics in BHK-R1
cells among these viruses (Fig. 1). We compared the size
of the syncytia produced by these viruses. In BHK-R1 and
BHK-R2 cells infected and incubated at 37°C for 12 to
15 h, we analyzed syncytia formed with NIH image soft-
ware. As shown in Fig. 2A and B, the syncytia formed on
BHK-R2 cells by srr7A and srr7B were significantly larger
(P  0.001) than those produced by srr7, but signifi-
cantly smaller (P  0.001) than those of wt virus. In
contrast, there was no size difference in syncytia pro-
duced in BHK-R1 cells by srr7, srr7A, and srr7B, although
these syncytia were revealed to be slightly, but signifi-
cantly smaller than those produced by the wt virus (P 
0.001) (Fig. 2B). These findings indicated that the fuso-
genicity of srr7A and srr7B reverted, if not perfectly, into
the wt-like feature in BHK-R2 cells, but not in BHK-R1
cells, and correlated well with the growth capacity in
BHK-R2 cells as shown in Fig. 1.
To compare the efficiency of infection in BHK-R2 cells
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as well as BHK-R1 cells, we examined the infectious
centers and plaquing efficiencies of wt and mutant vi-
ruses. An infectious center assay demonstrated that
srr7A and srr7B infected BHK-R2 cells with an efficiency
similar to that of the wt virus rather than to srr7, whereas
there was no remarkable difference in infection of
BHK-R1 cells among these four viruses (Fig. 3). Also, the
plaquing efficiency of those two mutants was similar to
that of wt virus, but far higher than srr7 in BHK-R2 cells,
although there was no difference in BHK-R1 cells (data
not shown). These results demonstrated that srr7A and
srr7B were more similar to the wt virus than to srr7 in
terms of growth and cytopathic effects on BHK-R2 cells.
Thus, those mutants were defined as phenotypical rever-
tants of srr7, and those revertants were revealed by a
virus overlay protein blot assay to bind to MHVR1 or
MHVR2 as efficiently as wt cl-2 and srr7 (data not
shown).
To compare the amino acid sequences of these rever-
tant S proteins with those of wt and srr7, we directly
sequenced the cDNA to the S genes of these viruses
amplified by RT-PCR, as described in Materials and
Methods. Amino acid sequences of these S proteins, as
deduced from nucleotide sequences, contained a muta-
tion at position 286 (Ser to Ile) in srr7B and two mutations
at positions 278 (Ile to Leu) and 461 (Ser to Thr) in srr7A
(Table 1). Relative to wt, these two revertants had a
mutation as well at position 1114 (Leu to Phe), which
stemmed from the parent srr7 (Table 1). Mutated amino
acids 286 and 278, found in srr7B and srr7A, respectively,
were revealed to lie in the third common region of
S1N330 (S1N330-III), consisting of amino acids 278 to
288, which was shown to be one of three conserved
regions at the receptor-binding site (Suzuki and Taguchi,
1996). The deduced sequence results suggested that
amino acid mutations in S1N330-III found in both rever-
tants are important for the phenotypic reversion of srr7 to
the wt virus. They also suggested that inefficient infec-
tion of srr7 in BHK-R2 cells caused by the mutation at
1114 of the wt virus S protein could be compensated for
by the additional mutation in S1N330-III.
Fusogenicity of mutant S proteins in BHK-R2 cells
Wt S protein was demonstrated to induce large syn-
cytia in BHK-R2 cells, while srr7 S protein failed to do so,
which resulted in a difference in efficiency of infection
between wt virus and srr7 in BHK-R2 cells (Matsuyama
and Taguchi, 2000). We have compared the fusion activity
of srr7A and srr7B in BHK-R2 cells with that of srr7 and
the wt cl-2. Srr7A and srr7B S genes were inserted into
a pTarget vector for expression, as described in Materi-
als and Methods. These vectors and those containing wt
S and srr7 S genes were transfected into BHK-R2 or
BHK-R1 cells, and their fusogenicity was examined by
using recombinant vaccinia virus vTF7.3 to express T7
RNA polymerase. Transfection efficiencies of these vec-
tors were assessed by the activity of luciferase ex-
pressed from the cotransfected plasmid. As shown in
Figs. 4A and 4C, the wt S showed strong fusion activity,
while srr7 S failed to induce efficient fusion in BHK-R2
cells, as reported previously (Matsuyama and Taguchi,
2000). However, both srr7A and srr7B S proteins induced
fusion in BHK-R2 cells similar to that induced by the wt
virus rather than to that induced by srr7 (Figs. 4A and 4C).
To see which of two mutations in the srr7A S protein is
important for fusion activity, we have prepared vectors
containing a single mutation found in srr7A. Srr7A S with
a mutation in S1N330-III alone (srr7A-330III) displayed
fusion activity similar to that of the original srr7A, while
srr7A S protein with a mutation at position 461 (srr7A-
HVR) had lost fusion activity (Fig. 4B), indicating that
mutation in S1N330-III is responsible for fusion activity.
The kinetics of fusion formation of srr7A and srr7B in
BHK-R2 cells was also similar to that of wt virus; syncytia
started to appear at 4 to 5 h after vTF infection and
spread to most cells by 15 h. However, syncytia by srr7
were very restricted even at 15 h after infection. In con-
trast, all of these S proteins induced fusion extensively in
BHK-R1 cells, and most cells were included into syncytia
at 15 h after infection (Fig. 4A). These results indicated
that the mutation in S1N330-III enhanced the fusogenic-
ity of the S protein, which had been impaired by a
mutation at amino acid 1114. This result suggested either
that the mutation in S1N330-III enhances the fusion ac-
tivity independent of amino acid 1114 or that the combi-
nation of these two regions located a long distance apart
is critical for sufficient fusogenicity in BHK-R2 cells. To
see which is correct, we have constructed srr7A and
srr7B S genes without a mutation at amino acid 1114,
designated them srr7Aa and srr7Ba, respectively, and
examined their fusogenicity. Srr7Aa and srr7Ba S pro-
teins were unable to induce fusion in BHK-R2 cells as
FIG. 1. Growth of wt cl-2 and srr mutants in BHK-R1 and BHK-R2 cells.
Cells were infected with wt cl-2 or srr mutants at an m.o.i. of 0.1 and
cells, as well as culture fluids, were collected together at intervals after
infection. After three rounds of freeze–thawing and spinning at 3000
rpm for 10 min, virus titers in the supernatants were determined. The
titer is a mean value of three independent samples.
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well as in BHK-R1 cells (Fig. 4A). Inability of srr7Aa and
srr7Ba S proteins to induce syncytia was revealed to be
due to defects in oligomerization (data not shown). The
difference in fusogenicity in BHK-R1 and BHK-R2 cells
shown in Fig. 4 did not appear to result from the differ-
ence in the amounts of S proteins expressed, because,
as shown in Fig. 5, there was no apparent difference in
the amounts expressed. It was noted that S2 with a
mutation at amino acid 1114, as seen in srr7, srr7A, and
srr7B S proteins, moved slightly faster than the S2 with-
out mutation, although these S2 proteins did not differ in
molecular weight (Fig. 5). All of these S proteins, irre-
spective of their fusogenicity, were similarly oligomerized
and transported onto the cytoplasmic membrane (data
FIG. 2. Syncytia formed by wt cl-2 and srr mutants. (A) Syncytia produced by wt cl-2 and srr mutants in BHK-R2 cells. BHK-R2 cells prepared in
24-well plates were infected with about 100 PFU of either wt cl-2 or srr mutants and microscopically observed at 15 h after infection. (B) BHK-R1 and
BHK-R2 cells cultured in 24-well plates were infected with about 100 PFU of virus, and syncytia were observed at 15 h after infection by microscopy.
The size of more than 20 syncytia for each virus was analyzed by NIH image. The vertical line extending above each bar indicates the standard
deviation.
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not shown). These results suggested that the combina-
tion of these two regions played a critical role in fusion
formation rather than that the mutation in S1N330-III
enhanced the fusion activity irrespective of amino acid at
1114.
Taken together, the present study, which was summa-
rized in Fig. 6, indicated that additional mutations in
S1N330-III found in srr7A and srr7B enhanced the fusion
activity of srr7 S protein to the level of the wt S protein.
However, this enhancement was not simply caused by a
mutation in S1N330-III alone, but was dependent on the
combination of amino acids in S1N330-III and at 1114.
DISCUSSION
Two srr mutants, srr7 and srr11, showed heavily re-
duced growth in BHK-R2 cells, which originated from
their reduced entry into the cell (Matsuyama and Tagu-
chi, 2000). The former has a mutation in S2 and the latter
in S1 (Saeki et al., 1997). To further analyze the region in
the S protein important for fusion in BHK-R2 cells, we
tried to isolate the revertant viruses from those two srr
mutants in terms of growth in BHK-R2. After several
passages through BHK-R2 cells, srr11 could no longer be
detected. Srr11 could not adapt to grow in BHK-R2 cells,
which implies that Leu at position 65 mutated to His in
srr11 is critical for efficient infection in BHK-R2 cells.
Because this amino acid is located within S1N330-I, one
of the two most important regions for receptor-binding
activity in S1N330 (Kubo et al., 1994; Suzuki and Taguchi,
1996), it could play a vital role in receptor binding. As
expected, the binding of srr11 to both BHK-R1 and
BHK-R2 cells was slightly reduced relative to wt and srr7
(Matsuyama and Taguchi, 2000; Saeki et al., 1997). The
inability of srr11 to adapt to BHK-R2 cells might be due to
this low receptor-binding capacity, or to double defects in
fusogenicity and receptor binding, as shown previously
(Matsuyama and Taguchi, 2000; Saeki et al., 1997).
Srr7 could successfully be adapted to grow in BHK-R2
cells by repeated passage through this cell line. This
biological change was accompanied by an amino acid
change in S1. Srr7B had only one additional mutation in
S1N330-III; however, srr7A contained two, one in
S1N330-III and the other in HVR of S1. The mutation in
the S1N330-III, but not that in the HVR, was revealed to
be responsible for the acquisition of fusion activity by
srr7A. Thus, the mutation in S1N330-III must be critical
for conversion from the srr7-type virus, which is ineffi-
cient in infecting in BHK-R2 cells into the wt-like virus
with efficient infection and fusion activity. However, the
amino acid changes in S1N330-III alone did not enhance
fusion activity, as seen for srr7Aa or srr7Ba, but a simul-
taneous mutation at position 1114 was inevitable. These
findings strongly suggest that the combination of
S1N330-III and the amino acid at 1114, presumably 1114
and its neighbors common to various MHV strains
(Kunita et al., 1995; Luytjes et al., 1987; Parker et al., 1989;
Taguchi et al., 1992; Yamada et al., 1997; Yamada and
Yabe, 2000), determines the fusogenic feature of the S
protein. It is not evident at present how S1 and S2
FIG. 3. Infectious centers produced by wt cl-2 and srr mutants on
BHK-R1 and BHK-R2 cells. BHK-R1, BHK-R2, and BHK cells were in-
fected either with wt or mutant viruses (m.o.i.  1) and cultured 3 h.
After washing three times with PBS containing 0.5% BSA and 0.05%
Tween 20, cells were treated with trypsin. Then, 10-fold serial dilutions
of the cells were overlaid onto DBT cell monolayers and cultured in
DMEM containing 0.5% methylcellulose for 15 h. The plaques were
counted after staining with neutral red. The result is representative of
multiple independent experiments.
TABLE 1
Identification of S Protein Mutations in Adapted srr7
Virus
Substitution at the following positiona
Nucleotide Amino acid
832 857 1382 3340 278 286 461 1114
wt (JHMV cl-2) A G G C Ile Ser Ser Leu
srr7 —b — — T — — — Phe
srr7A C — C T Leu — Thr Phe
srr7B — T — T — Ile — Phe
a Nucleotide and amino acid positions were numbered from the first ATG codon and methionine, respectively.
b —, Identity with the wild-type sequence.
164 MATSUYAMA AND TAGUCHI
FIG. 4. (A) and (B) Fusion activity of wt cl-2 and srr mutant S proteins in BHK-R1 and BHK-R2 cells. BHK-R1 and BHK-R2 cells were transfected with
plasmids containing various S genes or plasmid alone and infected with vTF7.3. After 15 h incubation, cells were fixed with formaldehyde and stained
with hematoxylin and eosin. (C) Fusion activity of the various S proteins as accessed by -galactosidase activity. Target cells, either BHK-R1 or BHK-R2
cells, were infected with wt vaccinia virus, then transfected with plasmid pG1NT7-gal and cultured in 96-well plates for 15 h. Onto these cells, effector
cells, from the same cell line infected with vTF7.3 and transfected with pTarget vector containing either wt or mutant S genes, were overlaid and
cultured for 7 h. The -galactosidase activity expressed as a result of fusion of effector and target cells was measured.
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interact to execute fusion, but it is not surprising in
coronavirus S protein that two regions a long distance
apart in primary structure cooperatively interact to exe-
cute an important biological function. Interaction or prox-
imal localization in the tertiary structure of S1 and S2 in
the native S protein was suggested by Grosse and Sid-
dell (1994), who isolated a MAb-resistant mutant with a
mutation in S2 after neutralization by S1-specific MAb.
The present study demonstrated that a combination of
S1N330-III and amino acid 1114 is important for MHV
entry to cells expressing MHVR2. However, such a strict
combination was not necessary for entry into cells ex-
pressing MHVR1. This difference could be accounted for
by the difference in virus-binding ability between MHVR1
and MHVR2. The former has more than at least 100-fold
higher binding ability than the latter, as examined by
virus overlay protein blot assay and neutralization tests
using soluble forms of these MHV receptors (Ohtsuka et
al., 1996; Zelus et al., 1998). Tight binding of MHV to the
receptor could compensate for the combination undesir-
able for efficient entry into cells found in srr7 S protein.
S1N330-III, consisting of 11 amino acids at positions
278 to 288 in S1, has been demonstrated to be perfectly
conserved among the seven MHV strains examined (Su-
zuki and Taguchi, 1996). Furthermore, this region is also
conserved in three newly isolated MHVs (Kunita et al.,
1995; Yamada and Yabe, 2000), and such conservation is
suggestive that S1N330-III retains some biological func-
tion critical for MHV replication. We suspected it to be
involved in receptor binding, because it was located in
S1N330, the receptor-binding domain. Site-directed mu-
tagenesis analysis showed, however, that S1N330-III
was the least involved in receptor-binding activity in the
three conserved regions in S1N330 (Suzuki and Taguchi,
1996). S1N330-III of srr7A and srr7B contained a muta-
tion at positions 278 and 286, respectively, relative to the
wt or srr7 S protein; nevertheless, those S proteins
equally bound and infected both BHK-R1 and BHK-R2
cells. This is also suggestive that S1N330-III is not im-
portant for receptor-binding activity. One may argue that
srr7A and srr7B with a mutation in S1N330-III could have
FIG. 5. Western blot analysis of the expressed S proteins. BHK-R1
and BHK-R2 cells transfected with plasmids harboring various S genes
and infected with vTF7.3 as described above were lysed at 15 h after
transfection. The amounts of S proteins in each lysate were examined
by Western blotting using MAb specific to the S2 subunit and ECL.
FIG. 6. Summary of JHMV S protein structure and their fusion activity in BHK-R1 and BHK-R2 cells. Mutated amino acids in mutant S proteins were
shown by closed marks, while original amino acids in the wt virus were displayed by open ones.
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receptor-binding activity due to a second mutation at
1114 in S2, suggesting the possibility that S1N330-III is
important for receptor binding, but the latter is unlikely,
because the binding of the S protein to the receptor
takes place with S1N330 alone, without the cooperation
of the S2 subunit or other parts of S1 (Kubo et al., 1994).
All of these factors could suggest that S1N330-III plays
an important role not in receptor binding, but rather in
viral entry into cells.
Several regions or amino acids in the S protein have
been reported to be important for fusion activity (Gal-
lagher, 1996; Gallagher et al., 1991; Luo and Weiss, 1998;
Luo et al., 1999; Taguchi and Shimazaki, 2000). All of
those, such as heptad repeats and amino acid position
1114, are located in the S2 subunit. Alterations from Leu
to Arg at position 1114 resulted in the reduced fusion
activity in DBT cells expressing MHVR1, suggesting the
importance of this amino acid for fusion activity (Gal-
lagher et al., 1991). We also described in the present
study that srr7 with an alteration of the same amino acid
from Leu to His has reduced fusion activity in BHK-R1,
which strengthened the importance of 1114 Leu for fu-
sion. A variant virus S protein of MHV-4 (JHMV) contain-
ing a mutation at position 1114, as well as two other
mutations, showed pH-dependent fusion activity (Gal-
lagher et al., 1991). The pH-independent fusion activity of
srr7 and its revertants suggests no or minor involvement
of 1114 Leu in the pH dependence of fusion activity.
Whereas a number of reports suggest the importance
of S2 for fusion activity for viral entry into cells, there is
little to suggest the importance of S1. Tsai et al. (1999)
reported that a stretch of 12 amino acids in HVR is
important for fusion activity. They compared the S protein
of fusion-negative MHV-2 with that of fusion-positive
MHV-JHM (Schmidt et al., 1987), and 12 amino acids
deleted in MHV-2, but not in MHV-JHM, were identified
as being responsible for fusion activity. However, this
stretch is not important for virus entry into cells, because
MHV-2 is able to infect cells. Recently, Krueger et al.
(2001) reported that mutant JHMVs containing a deletion
in the HVR have reduced fusion activity in MHVR-depen-
dent and -independent infections. We also described that
JHMV sp-4 virus, with a 141-amino acid deletion in the
HVR, has a reduced fusion activity on DBT cells with
MHVR1, which was revealed by the slightly smaller
plaques relative to wt cl-2 (Matsubara et al., 1991). Sp-4
also showed reduced fusion activity in MHVR-indepen-
dent infection (Taguchi et al., 1999). However, these vi-
ruses can infect and grow in cells expressing MHVR1
with an efficiency higher than or similar to wt virus, in
spite of their low fusogenicity (Kreuger et al., 2001; Tagu-
chi et al., 1985; Matsubara et al., 1991). This clearly
indicates that HVR is not a vital region in viral entry into
cells. Taken together, HVR may influence fusion activity
of MHV but it does not affect the potential for virus entry
into cells.
In addition to the differing abilities of wt cl-2 and srr7
to infect BHK-R2 cells, we previously revealed another
biological difference between them that infection
spreads from wt-infected DBT cells to BHK cells deficient
in MHVR (called MHVR-independent infection), while
srr7 failed to spread in this fashion (Taguchi et al., 1999;
Taguchi and Matsuyama, 2002). Srr7A and srr7B, rever-
tants in terms of infective ability to BHK-R2 cells, are able
to spread to BHK cells by MHVR-independent infection
(data not shown), indicating that srr7A and srr7B are
reverted in terms of MHVR-independent infection as well.
These findings suggest that the mechanism to infect
cells with MHVR2 has some similarity to that of MHVR-
independent infection. We are currently studying the
mechanism underlying MHVR-independent infection us-
ing wt, srr7 as well as two revertants from srr7.
The present study showed that double mutations, one
in S1N330-III and the other at amino acid 1114, were
important for fusogenicity in BHK-R2 cells. This suggests
that these two regions interact with each other and
cooperatively execute fusion formation, namely viral en-
try into cells. How the combination of S1N330-III and
amino acid 1114 determines the fusion activity was not
addressed in this study. It is reported for retroviruses and
other viruses that the receptor-binding protein under-
goes conformational change after binding to the receptor
(Damico et al., 1998; Ikeda et al., 2000), which is an
essential step for virus entry into cells, via virus–cell
fusion. MHV S protein supposedly undergoes conforma-
tional change after binding to the receptor, which con-
verts the S protein to fusion active phenotype. Reduced
fusion activity of srr7 S protein in BHK-R2 cells could be
due to the lack of conformational change after binding to
the receptor. In contrast, the combination of these two
regions in wt virus, srr7A and srr7B, may permit or pro-
mote the conformational changes of the S protein. Stud-
ies are currently in progress to examine these possibil-
ities.
MATERIALS AND METHODS
Cells and viruses
The highly neurovirulent wt MHV-JHMV cl-2 (Taguchi
et al., 1985), as well as srr7 and srr11 derived from cl-2
(Saeki et al., 1997), were propagated on DBT cells (Ku-
manishi, 1967). Newly isolated mutants, srr7A and srr7B,
were propagated on DBT cells as well. DBT cells were
also used to estimate the infectivity of MHV. BHK cells as
well as BHK cells constitutively expressing MHV recep-
tor MHVR1 (BHK-R1) or MHVR2 (BHK-R2) (Matsuyama
and Taguchi, 2000) were used for MHV infection and
expression of S proteins. BHK cells lack the MHV recep-
tor and are thus nonpermissive to MHV infection. Recom-
binant vaccinia virus, vTF7.3, harboring the T7 RNA poly-
merase gene (Fuerst et al., 1986), kindly provided by B.
Moss, was propagated and plaque-assayed on RK 13
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cells. All cell lines used in this study were grown in
Dulbecco’s minimal essential medium (DMEM, Nissui,
Tokyo) supplemented with 5% fetal bovine serum (FBS,
Gibco BRL, Grand Island, NY).
Isolation of mutant viruses
To select the mutants that grow efficiently in BHK-R2
cells, srr7 and srr11, 5–10  105 PFU as examined using
DBT cells, were inoculated onto confluent BHK-R2 cells
prepared in a 35-mm dish (Costar, Cambridge, MA). Both
supernatants and cells were harvested at 24 h p.i. and
subjected to three rounds of freeze–thawing. After cen-
trifugation at 3000 rpm for 10 min, the clarified superna-
tants, 100 l containing 103 to 106 PFU of virus, were
further inoculated onto BHK-R2 cells. After 20 serial pas-
sages under similar conditions, two clones, srr7A and
srr7B, were obtained from srr7-infected BHK-R2 cells in
independent experiments. These mutants were plaque
purified further three times on DBT cells.
Assay of virus infectivity
We measured the MHV infectivity by inoculating 20 l
of virus dilution per well onto DBT cells cultured in
24-well plates and incubating them at 37°C for 1 h
(Taguchi and Matsuyama, 2002). Cells were then cul-
tured in DMEM containing 5% FBS and 0.5% methylcel-
lulose (Sigma, St. Louis, MO) at 37°C for 12 to 18 h.
Following fixation with formaldehyde, cells were stained
with 0.1% crystal violet. The syncytia counted under a
microscope (CK30, Olympus, Tokyo) were shown as PFU.
Estimation of syncytium (plaque) size
BHK-R1 and BHK-R2 cells prepared in 24-well plates
were infected with the wt and mutant viruses to produce
about 50–100 syncytia per well. Infected cells were cul-
tured in DMEM containing 5% FBS and 0.5% methylcel-
lulose for 15 to 18 h. Syncytia observed under a micro-
scope were analyzed for their size by NIH image (a
public domain software). Syncytium sizes of viruses were
statistically compared using Student’s t test.
Infectious center assay
Infectious centers were tested using BHK-R1, BHK-R2,
and BHK cells as described previously (Matsuyama and
Taguchi, 2000). Those cells cultured in 35-mm dishes
were infected with wt or mutant viruses (m.o.i.  1) and
incubated at 37°C for 1 h. After washing twice with
phosphate-buffered saline (PBS), pH 7.2 containing 0.5%
BSA and 0.05% Tween 20, the cells were incubated in
DMEM containing 3% FBS at 37°C for 3 h. In some
experiments, cells were treated with anti-JHMV MAbs
(Kubo et al., 1993) to neutralize remaining infectious
viruses. The cells were treated with trypsin and washed
three times with DMEM by spinning 1500 rpm for 5 min.
Then, the 0.1 ml of 10-fold dilutions of infected cells were
overlaid onto confluent DBT cells prepared in 35-mm
dishes. After culture for 15 h at 37°C in DMEM supple-
mented with 0.5% methylcellulose, the cells were stained
with neutral red and plaques were counted.
Isolation and expression of S genes
DBT cells prepared in 60-mm dishes were infected
with srr7A or srr7B at an m.o.i. of 1. Total RNA was
isolated from those cells at 15 h after inoculation with an
Isogen RNA extraction kit (Nippon Gene, Tokyo, Japan).
Srr7A and srr7B S cDNAs were made by reverse-tran-
scription (RT)-PCR from isolated RNA with a pair of prim-
ers as previously described (Matsuyama and Taguchi,
2000), and the PCR products were directly sequenced
(Sanger et al., 1977). To obtain the mutant S genes for
expression, the amplified DNAs were cloned into a com-
mercial expression vector, pTarget (Promega, Madison,
WI). As the S genes integrated into the vector contained
some nucleotide differences relative to authentic mutant
S genes, we have constructed the mutant S genes by
replacing srr7 S gene with DNA fragments containing
mutations specific for srr7A or srr7B. Because the wt and
srr7 S genes previously constructed had three amino
acid mutations (Matsuyama and Taguchi, 2000), com-
pared to the originally reported S genes (Taguchi et al.,
1992, 1995), we newly prepared the vectors that contain
the authentic S genes, pTargetcl-2S and pTargetsrr7S.
The pTargetsrr7S plasmid harboring the srr7 S gene
downstream from the T7 promoter (Matsuyama and
Taguchi, 2000) was cut with PfIM I at nucleotide 749 and
Apa I at 1548 calculated from the first nucleotide of the S
gene initiation codon. The resulting 800-bp fragment was
replaced with the corresponding fragment of srr7A and
srr7B. Srr7A and srr7B S genes without a mutation at
amino acid 1114 were also constructed by replacing the
fragment containing the mutation with the fragment of wt
virus as described previously (Matsuyama and Taguchi,
2000). They were named pTargetsrr7Aa and pTargetsrr-
7Ba. We constructed srr7A containing only one mutation
in S1N330-III, srr7A-330III, and that with a mutation at
position 465, srr7A-HVR, by exchanging the srr7 and
srr7A fragments cut with Sca I. Sca I cuts pTargetsrr7
and pTargetsrr7A at two positions, one in JHMV S gene
at position 2183 between two mutations found in srr7A
and the other in pTarget vector at position 8412. Thus,
digestion by Sca I results in two fragments; one is JHMV
S gene 5 fragment containing a mutated region in
S1N330-III alone (3.5 kb) and the other JHMVS 3 frag-
ment containing mutated HVR alone (6.3 kb). Srr7A-330III
S is a chimera consisting of srr7A S 5 3.5 kb and srr7 3
6.3 kb fragments. The Srr7A-HVR S gene is composed of
fragments of srr7 5 3.5 kb and srr7A 3 6.3 kb. The
constructed plasmids were confirmed by sequencing
(Sanger et al., 1977). S proteins of wt and mutants were
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expressed using recombinant vaccinia virus vTF7.3 har-
boring the T7 RNA polymerase gene as previously de-
scribed (Saeki et al., 1997).
Western blot
S proteins expressed in BHK-R1 and BHK-R2 cells
after transfection with vectors containing various S
genes were analyzed by Western blotting using anti-S
MAbs kindly provided by S. G. Siddell (Routledge et al.,
1991) by enhanced chemiluminescence (ECL, Amer-
sham, Arlington Heights, IL) as previously reported (Mat-
suyama and Taguchi, 2000).
Fusion activity
Fusion activities of wt and mutant S proteins were
examined principally as reported by Nussbaum et al.
(1994). BHK-R1 and BHK-R2 cells were used for this
assay. The same type of cells were used for target and
effector cells. Target cells were infected with wt vaccinia
virus WR strain (m.o.i.  10) and incubated at 37°C for
1 h. Those cells (1  107 cells) were then transfected
with 10 g of pG1NT7-gal harboring -galactosidase
gene downstream of the T7 promoter, kindly provided by
Dr. E. Berger (Nussbaum et al., 1994), by electroporation
as described previously (Ohtsuka et al., 1996). These
cells were distributed in collagen-coated, 96-well plates
(Iwaki), 5  104 cells/well, in DMEM supplemented with
5% FBS and incubated at 37°C for 15 h before being
overlaid by effector cells. Effector cells were infected
with vTF7.3 (m.o.i.  10) and incubated at 37°C for 1 h
and they (106 cells) were transfected with 5 g of pTarget
vectors containing either wt or mutant S genes together
with 0.5 g of plasmid containing firefly luciferase gene
pTM-luc (Aoki et al., 1998), kindly provided by Dr. Y.
Matsuura, by electroporation. The pTM-luc was used to
measure the transfection efficiencies of each vector to
express various S proteins. Those treated cells, 5  104
cells/well, were overlaid onto target cells prepared in
96-well plates and mixed cells were further cultured at
37°C for 6 to 8 h. The activity of -galactosidase ex-
pressed as a result of fusion of effector and target cells
by expressed S protein was measured using a commer-
cial kit (Promega, -galactosidase enzyme assay sys-
tem) as recommended by manufacturer.
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